Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$305M |
| 2 |
Procter & Gamble
PG
|
+$300M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$274M |
| 4 |
NVIDIA
NVDA
|
+$268M |
| 5 |
Lowe's Companies
LOW
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.23B |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$536M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$470M |
| 4 |
ExxonMobil
XOM
|
+$370M |
| 5 |
Amazon
AMZN
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.61% |
| 2 | Technology | 13.44% |
| 3 | Consumer Discretionary | 5.63% |
| 4 | Financials | 5.29% |
| 5 | Healthcare | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3501
Fulcrum Therapeutics
FULC
$281M
| $407K | ﹤0.01% |
109,956
-16,602
| -13% | -$62.3K |
2025 Q2
5 quarters
|
|
3502
1stdibs.com
DIBS
$199M
| $407K | ﹤0.01% |
101,706
+22,336
| +28% | +$101K |
2026 Q2
1 quarter
|
|
3503
Genworth Financial
GNW
$3.08B
| $407K | ﹤0.01% |
45,321
-579,768
| -93% | -$5.73M |
2019 Q4
27 quarters
|
|
3504
Cass Information Systems
CASS
$708M
| $406K | ﹤0.01% |
7,624
-8,640
| -53% | -$477K |
2025 Q4
3 quarters
|
|
3505
Ternium
TX
$9.9B
| $406K | ﹤0.01% |
+7,473
| New | +$388K |
2026 Q3
0 quarters
|
|
3506
Empire State Realty Trust
ESRT
$827M
| $405K | ﹤0.01% |
100,524
-35,553
| -26% | -$172K |
2025 Q2
5 quarters
|
|
3507
SmartFinancial
SMBK
$819M
| $404K | ﹤0.01% |
8,153
-7,286
| -47% | -$368K |
2026 Q1
2 quarters
|
|
3508
Peapack-Gladstone Financial
PGC
$816M
| $404K | ﹤0.01% |
+9,263
| New | +$424K |
2026 Q3
0 quarters
|
|
3509
Cogent Biosciences
COGT
$5.07B
| $403K | ﹤0.01% |
+12,601
| New | +$466K |
2026 Q3
0 quarters
|
|
3510
Nuvectis Pharma
NVCT
$696M
| $403K | ﹤0.01% |
+19,095
| New | +$403K |
2026 Q3
0 quarters
|
|
3511
Alibaba
BABA
$235B
| $403K | ﹤0.01% |
3,748
-61,586
| -94% | -$7.12M |
2021 Q3
20 quarters
|
|
3512
Polaris
PII
$3.68B
| $403K | ﹤0.01% |
+7,721
| New | +$499K |
2026 Q3
0 quarters
|
|
3513
Tamboran Resources
TBN
$1B
| $402K | ﹤0.01% |
+12,209
| New | +$431K |
2026 Q3
0 quarters
|
|
3514
PTC
PTC
$21.3B
| $402K | ﹤0.01% |
2,867
-2,627
| -48% | -$361K |
2023 Q2
13 quarters
|
|
3515
PUT
Stellantis
STLA
$11.2B
| $402K | ﹤0.01% |
92,100
-193,400
| -68% | -$1.04M |
2022 Q3
16 quarters
|
|
3516
OneSpaWorld
OSW
$3.07B
| $401K | ﹤0.01% |
17,827
-37,214
| -68% | -$934K |
2026 Q2
1 quarter
|
|
3517
SEALSQ Corp
LAES
$297M
| $401K | ﹤0.01% |
171,299
-8,555
| -5% | -$21.6K |
2025 Q3
4 quarters
|
|
3518
Pitney Bowes
PBI
$2.12B
| $400K | ﹤0.01% |
24,534
-50,751
| -67% | -$876K |
2026 Q1
2 quarters
|
|
3519
Direxion Daily MU Bull 2X ETF
MUU
$2.27B
| $400K | ﹤0.01% |
+10,865
| New | +$343K |
2026 Q3
0 quarters
|
|
3520
ARS Pharmaceuticals
SPRY
$383M
| $400K | ﹤0.01% |
92,796
+67,892
| +273% | +$397K |
2026 Q1
2 quarters
|
|
3521
MGE Energy Inc
MGEE
$2.99B
| $399K | ﹤0.01% |
5,743
-4,864
| -46% | -$383K |
2024 Q4
7 quarters
|
|
3522
CALL
MACOM Technology Solutions
MTSI
$18.8B
| $399K | ﹤0.01% |
1,400
-12,200
| -90% | -$3.42M |
2026 Q2
1 quarter
|
|
3523
PUT
NexGen Energy
NXE
$5.41B
| $399K | ﹤0.01% |
43,700
-25,500
| -37% | -$250K |
2026 Q2
1 quarter
|
|
3524
National Presto Industries
NPK
$1B
| $397K | ﹤0.01% |
2,681
-4,530
| -63% | -$628K |
2026 Q2
1 quarter
|
|
3525
Navan Inc
NAVN
$6.82B
| $396K | ﹤0.01% |
+18,877
| New | +$486K |
2026 Q3
0 quarters
|
|
Similar funds
Squarepoint's Q3 2026 Portfolio in Review
As of Q3 2026, Squarepoint held 5,201 positions worth $90.8B, up 0.33% from $90.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Squarepoint withdrew a net $4.18B in Q3 2026, closing 849 positions and reducing 1,820 holdings. Its most notable exit was Electronic Arts, an estimated $146M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Squarepoint opened a new position in AstraZeneca worth $188M.
- Squarepoint's largest Q3 2026 buy was AstraZeneca: 1,161,691 shares worth $188M.
- Squarepoint added most to Costco in Q3 2026, an estimated $305M increase.
- Squarepoint's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.23B.
- Squarepoint fully exited Electronic Arts in Q3 2026, selling an estimated $146M.
- Squarepoint's ten largest holdings make up 22% of its $90.8B portfolio in Q3 2026.
- Squarepoint opened 873 new positions and closed 849 in Q3 2026.
- Squarepoint's portfolio value rose 0.33% quarter-over-quarter to $90.8B.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.